Background. Invasive fungal infections due to less-common molds are an increasing problem, and accurate diagnosis is difficult.
There is a gradual and significant shift toward new fungal opportunists in the etiology of invasive fungal infection (IFI) [1, 2] . Diagnosis of IFI is difficult, and new methods are required that allow species identification in histologically proven cases.
Many fungi have similar histological features, and hyphae tend to be identified as representing Aspergillus species by default. Species identification can be achieved with tissue culture, but this method only yields a result in ∼50% of cases . Immunohistochemical [6, 7] and in situ hybridization techniques [8] [9] [10] [11] [12] [13] have been evaluated, but their use is restricted to very few pathogens. PCR amplification of fungal DNA extracted from both fresh [14] and formalin-fixed paraffin-embedded (wax) [4] tissue sections has been reported.
Until recently, routine resection of pulmonary fungal lesions was performed in all operable cases in our institution [15] , providing an invaluable collection of ar-chived tissue samples. A number of tissue samples have also been obtained by diagnostic biopsy and postmortem examination.
We have previously described a molecular method capable of identifying fungal pathogens in wax tissue sections [16] . The aim of this study was to confirm the validity of this method by testing our collection of tissue samples and, in doing so, determine the incidence of IFI due to less-common molds in our institution. Cases of zygomycosis were not investigated, because their histological appearances are characteristic.
MATERIALS AND METHODS
Wax tissue specimens from 56 patients treated in the hematology department of the Royal Free Hospital between 1982 and 2000 who had histologically-proven IFI suggestive infection with of a mold not from the Zygomycetes family were identified from pathology records. Ten-micrometer sections were cut from each specimen; a new sterile blade was used for each one (outer sections were discarded).
Mycological culture results for the 56 patients were analyzed and were used to divide the patients into groups. Group A was made up of patients with a tissue culture positive for Aspergillus fumigatus or Aspergillus flavus; group B patients had a tissue culture positive for a lesscommon mold; group C patients had a negative tissue culture result but a positive result of culture of a sample from another site (e.g., from a bronchoalveolar lavage fluid specimen); and group D patients had no positive tissue culture results.
In addition to archived wax sections of normal lung tissue, specimens of tissue with histological evidence of other infective pathogens-including Mycobacterium tuberculosis, cytomegalovirus, Pneumocystis jiroveci, and gram-positive cocci-were used as controls.
DNA was extracted using a method based on the TaKaRa Dexpat kit (TaKaRa Biomedicals), as described elsewhere [16] . Panfungal primers were used for PCR amplification, and Southern blot hybridization was performed using a DNA probe specific for A. fumigatus, A. flavus, and Aspergillus versicolor [16, 17] . PCR products that did not hybridize with the probe, despite attempts, were purified with the Wizard PCR Preps DNA Purification System (Promega). Purified DNA was sequenced commercially (by Cytomyx, Cambridge, United Kingdom), and sequence analysis was performed with the Emboss software package ,(Human Genome Mapping Project-Resource Center, UK Medical Research Council). Sequences were identified using a BLAST search of GenBank and European Molecular Biology Laboratory (EMBL) nucleotide sequence databases.
RESULTS
Sixty-seven wax tissue specimens from 56 patients with IFI were tested (table 1). Species identification for groups A and B correlated with results of tissue culture, confirming the validity of the method. Sequence analysis of DNA from patient 24 (group B) confirmed infection with Chaetomium globosum, and sequence data were submitted to the EMBL nucleotide sequence database (accession number AJ781794). The isolate cultured from the lung tissue of patient 24 has been added to the UK National Collection of Pathogenic Fungi (NCPF catalog number 7115). Sequencing of genomic DNA from a subculture of this isolate yielded a sequence that was identical to that obtained from the tissue sample, which confirmed the causative role of this organism in this case. Likewise, the results of the sequence analysis of DNA extracted from tissue samples and the clinical isolate cultured from a tissue sample from patient 25 (group B) were identical, and both were identified as Scedosporium apiospermum (EMBL nucleotide sequence database accession number AJ812012).
In group C, 6 patients had negative tissue culture results, but cultures of samples from other sites were positive for A. fumigatus or A. flavus. IFI due to A. fumigatus or A. flavus was molecularly confirmed in 4 (67%) of these patients. Patient 29 had a positive PCR result, but the results of Southern blotting were negative. Sequencing of purified DNA revealed Candida glabrata (EMBL nucleotide sequence database accession number AJ842962). Cultures of sputum samples initially yeilded a scanty growth of A. fumigatus and subsequently grew C. glabrata. Histological examination revealed that necrotic tissue had extensively infiltrated by branched, septate fungal hyphae, in keeping with Aspergillus infection, along with numerous Candida spores on the surface of the material. Therefore, only the colonizing organism was identified by molecular analysis. The results of culture were negative for patient 31, and histological examination revealed only small clusters of Aspergillus organisms in alveolar walls.
Of the 25 patients with no positive fungal culture results (group D), it was possible to establish a diagnosis of infection with A. fumigatus or A. flavus in 21 (84%). Samples from patients 43 and 51 yielded positive PCR results but negative Southern blot results. A short sequence of 179 bases was available for analysis from patient 43 (EMBL nucleotide sequence database accession number AJ850082). Using a BLAST search, we found this sequence to have a high degree of homology with Alternaria alternata, and other Alternaria species (Alternaria malorum, Alternaria selini, Alternaria petroselini, Alternaria japonica, Alternaria brassicicola, and Alternaria raphani) and Ulocladium species (Ulocladium botrytis, Ulocladium atrum, and Ulocladium alternariae) (figure 1). Attempts to sequence DNA from patient 51 failed, despite the preparation of PCR amplimers on separate occasions. The cause of infection in this patient's case was thought to be a mold other than A. fumigatus or A. flavus. The diagnosis could not be confirmed for patients 33 and 41, because the results of both PCR and Southern blot hybridization were negative. Histological examination of patient 33 revealed only that scanty Aspergillus had been seen.
Results are summarized in table 2. In total, a diagnosis of IFI caused by A. fumigatus or A. flavus was made in 48 cases (86%), and a diagnosis of IFI due to less-common molds was made in 4 cases (7%). A molecular diagnosis could not be established in 4 cases (7%). Results for all control samples were as expected.
The 4 cases of IFI due to less-common molds occurred in the 1990s: case 1 (1992) was probably casued by Alternaria species, case 2 (1994) was caused by Chaetomium globosum, case 3 (1995) was caused by an unidentified mold, and case 4 (1997) was caused by Scedosporium apiospermum (figure 2). Cases of histologicallyconfirmed zygomycosis that occurred in our institution over this time period are also shown in figure 2.
DISCUSSION
The results of this study-species identification achieved in 52 (93%) of 56 cases-confirm the validity and clinical applicability of our previously developed method for identifying molds in wax tissue specimens. This compares favorably with results published by Willinger et al. [4] , who used molecular methods to test wax tissue sections from patients with proven IFI of the maxillary sinuses, and who achieved species identification in 58% of cases. Confirmation of the causative organism was made in all cases that had positive tissue culture results. Of the cases that had negative tissue culture results, molecular identification was not achieved in 4. These cases may have been caused by less-common molds, and the quantity of DNA extracted might have been insufficient for detection by PCR alone. However, in 2 cases, only scant hyphae were noted on histological examination, and therefore, A. fumigatus or A. flavus DNA may not have been detected, even after Southern blotting. Only the colonizing organism was identified in patient 29 (in group C).
Definitive identification of the mold in the specimen from patient 43 (in group D) was difficult because of the shortness of the DNA sequence that was suitable for analysis and the high degree of sequence homology that exists between Alternaria species and Ulocladium species. It is likely that the causative organism in this case was an Alternaria species, although the sequence was also highly homologous with Ulocladium spe-cies. Both Alternaria and Ulocladium species are dematiaceous fungi that usually act as soil saprophytes and plant pathogens. Some Alternaria species, most commonly A. alternata, are recognized causes of IFI [18, 19] . To date, Ulocladium species have only been reported to cause cutaneous infections [20] .
Our method revealed that the incidence of IFI due to lesscommon molds in our institution was 7% (4 of 56 cases of IFI). There were no clinical, radiological, or histological features to indicate an unusual cause of infection in any of these cases. We have previously reported details of the case of C. globosum infection in patient 24 [21, 22] . The 4 patients in whom IFI was caused by less-common molds were profoundly immunocompromised, and it is easier for low-virulence organisms to take hold and cause infection in such clinically high-risk patients. In addition, antifungal prophylaxis had been administered to these 4 patients for prolonged periods, and this may have allowed more-resistant molds to be selected. A major concern regarding the emergence of these molds is that they are not universally susceptible to amphotericin B. Despite therapy, all 4 patients died, and all had documented evidence of active IFI at the time of death.
It appears that the incidence of infection with less-common molds may be increasing. All 4 cases caused by less-common molds in our institution occurred in the 1990s, as did 3 cases in which the diagnosis was not confirmed by molecular methods and 3 cases of zygomycosis (figure 2). The overall incidence of IFI with less-common molds in our institution from 1982 to 2000 is therefore 12% (7 of 59 cases of IFI).
In conclusion, given the increasing incidence of infection with less-common molds that have varying sensitivity to antifungal agents, institutions should continue to vigorously pursue diagnosis of IFI by means of tissue culture and microbiologic analysis. Our method is a valuable diagnostic tool for both patient management and future epidemiological and diagnostic studies.
